Your browser doesn't support javascript.
loading
The impact of implementation of the Canadian regulatory requirements on the quality of natural health products: the glucosamine case.
Aghazadeh-Habashi, Ali; Duke, John; Jamali, Fakhreddin.
Affiliation
  • Aghazadeh-Habashi A; Faculty of Pharmacy and Pharmaceutical Sciences University of Alberta.
J Pharm Pharm Sci ; 17(1): 20-4, 2014.
Article in En | MEDLINE | ID: mdl-24735759
ABSTRACT

PURPOSE:

We investigated whether the recent implementation of the regulatory requirements for the entry to the Canadian market of natural products has resulted in improved quality of the available glucosamine products.

METHODS:

Eleven available products, of which 8 had been tested in 2002 (7 had contained substantially lower than the label claim of the active ingredient), and a European pharmaceutical grade tablet were assayed for their glucosamine content. The potassium and sodium contents of the products were also tested.

RESULTS:

Nine of the 11 Canadian products and the European tablet had more than 91% of the label claim of the active ingredient, hence, met the criterion. Two products contained 71 and 78% label claim. The electrolyte contents were very variable but constituted only a small fraction of the daily requirements.

CONCLUSION:

Most tested glucosamine products passed the Health Canada requirements. This improvement is likely due to the publicity regarding the low quality of the products in the past and also a result, at least in part, of the introduction of the new regulatory requirements. The sub-standard quality of a few tested products is still of concern.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Drug and Narcotic Control / Glucosamine Limits: Humans Language: En Journal: J Pharm Pharm Sci Journal subject: FARMACIA / FARMACOLOGIA Year: 2014 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Drug and Narcotic Control / Glucosamine Limits: Humans Language: En Journal: J Pharm Pharm Sci Journal subject: FARMACIA / FARMACOLOGIA Year: 2014 Document type: Article